TJPC(SH:600488) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-07-31 23:22Core Points - The company received a GMP compliance inspection notice from the Tianjin Municipal Drug Administration, indicating that its production lines meet regulatory requirements [1][2] - The inspection covered multiple active pharmaceutical ingredients (APIs) including Prednisone, Methylprednisolone, Hydrocortisone Sodium Succinate, and Formoterol Fumarate, with specific production lines and workshops identified [1] - The inspection is scheduled from May 13 to May 16, 2025, and is based on the 2010 revision of the Drug Production Quality Management Standards [1] Company Impact - The receipt of the GMP compliance notice is expected to support the company's stable production capacity and leverage its integrated advantages in APIs and formulations to meet market demand [2] - The future sales performance of the products may be influenced by market environment changes, indicating potential uncertainties in the pharmaceutical market [2]